Mesenchymal Cell News Volume 14.02 | Jan 18 2022

    0
    27







    2022-01-18 | MESCN 14.02


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.02 – 18 January, 2022
    TOP STORY

    Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury

    The authors found that irisin pretreatment increased the cardiac homing of adipose tissue-derived MSCs administered by single and multiple intravenous injections to mice with myocardial ischemia-reperfusion by more than fivefold.
    [Advanced Science]

    Full Article

    ON712CXN-Cancer-728 x 90
    PUBLICATIONSRanked by the impact factor of the journal

    miR-204–Containing Exosomes Ameliorate GVHD-Associated Dry Eye Disease

    Investigators reported that exosomes from MSCs administered as eye drops notably alleviated graft-versus-host disease-associated dry eye disease by suppressing inflammation and improving epithelial recovery in mice and humans.
    [Science Advances]

    Full Article

    Short-Duration High Frequency MegaHertz-Order Nanomechanostimulation Drives Early and Persistent Osteogenic Differentiation in Mesenchymal Stem Cells

    Researchers showed that high-frequency MegaHertz-order mechanostimulation in the form of nanoscale amplitude surface reflected bulk waves were capable of triggering differentiation of human MSCs from various donor sources toward an osteoblast lineage.
    [Small]

    Abstract

    Upregulation of CD14 in Mesenchymal Stromal Cells Accelerates Lipopolysaccharide-Induced Response and Enhances Antibacterial Properties

    Scientists utilized a systems-based approach to compare MSCs from different genetic backgrounds that displayed differences in antibacterial activity.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Endometrial Stromal Cell Ferroptosis Promotes Angiogenesis in Endometriosis

    The authors revealed that endometrial stromal cell ferroptosis in the ovarian endometrioma may have triggered cytokine secretion and promoted angiogenesis of adjacent lesions via paracrine actions to drive the development of endometriosis.
    [Cell Death Discovery]

    Full Article

    Delivery of Affordable and Scalable Encapsulated Allogenic/Autologous Mesenchymal Stem Cells in Coagulated Platelet Poor Plasma for Dental Pulp Regeneration

    Investigators evaluated the potential of combining a natural and accessible biomaterial based on platelet poor plasma as a support for dental pulp stem cells and umbilical cord MSCs.
    [Scientific Reports]

    Full Article

    Hypoxia-Inducible Factor 1α Induces Osteo/Odontoblast Differentiation of Human Dental Pulp Stem Cells via Wnt/β-Catenin Transcriptional Cofactor BCL9

    Researchers examined the role of B-cell CLL/lymphoma 9 (BCL9), which is downstream of hypoxia-inducible factor 1α and a Wnt/β-catenin transcriptional cofactor, in the osteo/odontoblastic differentiation of human dental pulp stem cells under hypoxic conditions.
    [Scientific Reports]

    Full Article

    NAP1L2 Drives Mesenchymal Stem Cell Senescence and Suppresses Osteogenic Differentiation

    The authors screened the gene expression profiles of human bone marrow MSCs (BMSCs) from young and old donors and identified that elevation of the nucleosome assembly protein 1-like 2 (NAP1L2) expression was correlated with BMSC senescence and impaired osteogenesis.
    [Aging Cell]

    Full Article

    Nanoparticles Functionalized with Stem Cell Secretome and CXCR4-Overexpressing Endothelial Membrane for Targeted Osteoporosis Therapy

    Scientists fabricated nanoparticles (NPs) using polylactic-co-glycolic acid loaded with the secretome (Sec) from MSCs to form MSC-Sec NPs.
    [Journal of Nanobiotechnology]

    Full ArticleGraphical Abstract

    Human Amniotic Mesenchymal Stem Cells Combined with PPCNg Facilitate Injured Endometrial Regeneration

    The authors investigated the therapeutic effect of human amniotic MSCs combined with polyethylene glycol citrate-co-N-isopropylacrylamide mixed with gelatin (PPCNg) transplantation in promoting the regeneration of injured endometrium.
    [Stem Cell Research & Therapy]

    Full Article

    Effect of Lentivirus-Mediated Growth and Differentiation Factor-5 Transfection on Differentiation of Rabbit Nucleus Pulposus Mesenchymal Stem Cells

    Researchers investigated the biological and cytological characteristics of rabbit nucleus pulposus MSCs (NPMSCs) and determined the effect of the growth and differentiation factor-5 on the differentiation of rabbit NPMSCs transduced with a lentivirus vector.
    [European Journal of Medical Research]

    Full Article

    Are Your Pluripotent Stem Cells What You Think They Are? Explore Now.
    REVIEWS

    Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

    The authors overview the current knowledge regarding the therapeutic efficacy of MSCs in systemic sclerosis (SSc), focusing on progresses reported in preclinical and clinical studies using MSCs, as well as challenges and future directions of MSC transplantation as a treatment option for patients with SSc.
    [Clinical Reviews in Allergy & Immunology]

    Abstract

    Immunomodulatory Effects of Mesenchymal Stem Cells in Peripheral Nerve Injury

    Scientists summarize the known interactions between MSCs, immune cells, and inflammatory cytokines following peripheral nerve injuries with a focus on the immunosuppressive role of MSCs.
    [Stem Cell Research & Therapy]

    Full Article

    INDUSTRY AND POLICY NEWS

    Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase II Clinical Trial of COVI-MSC in COVID-19 Patients with Persistent Pulmonary Compromise after Recovery (Long-Hauler)

    Sorrento Therapeutics, Inc. announced receipt of clearance from ANVISA to proceed with a Phase IIa randomized, placebo-controlled study of intravenous allogeneic adipose-derived MSC to treat post COVID-19 “long haul” pulmonary compromise.
    [Sorrento Therapeutics, Inc.]

    Press Release

    FEATURED EVENT

    Cell Therapy Analytics Symposium

    2 March, 2022
    Online

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowships – Extracellular Vesicles, Microglia and Alzheimer’s disease

    Mayo Clinic Florida Campus – Jacksonville, Florida, United States

    Research Scientist – Genitourinary Tract Regenerative Medicine

    Boston Children’s Hospital – Boston, Massachusetts, United States

    Project Manager – Therapeutic Development Branch

    National Institute of Health – Rockville, Maryland, United States

    Research Associate – Cardiovascular Disease Modeling

    Cedars-Sinai Regenerative Medicine Institute – Los Angeles, California, United States

    Research Professor – Burn Care and Regenerative Medicine

    Centre de recherche du CHUM – Montreal, Quebec, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter